SQUAWK/NEWS
Menu
Live News EQUITY M impact

Immunovant Files SEC Form

Immunovant, Inc. files with SEC, disclosure pending. Immunovant is a biopharmaceutical company.

IMVT

Filed: 2026-05-28 AccNo: 0001950047-26-005198 Size: 9 KB